The clinical, laboratory, and radiologic improvement due to siltuximab treatment in idiopathic multicentric Castleman’s disease

BACKGROUND/AIMS: Idiopathic multicentric Castleman disease (iMCD) comprises approximately 30% of all cases of Castleman disease. It is characterized by constitutional symptoms, enlarged lymph nodes at multiple anatomical sites, and laboratory test abnormalities, which are primarily related to the ov...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Korean J Intern Med
Egile Nagusiak: Min, Gi-June, Jeon, Young-Woo, Park, Sung-Soo, Park, Silvia, Shin, Seung-Hawn, Yahng, Seung-Ah, Yoon, Jae-Ho, Lee, Sung-Eun, Cho, Byung-Sik, Eom, Ki-Seong, Kim, Yoo-Jin, Lee, Seok, Kim, Hee-Je, Min, Chang-Ki, Kim, Dong-Wook, Lee, Jong-Wook, Cho, Seok-Goo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Korean Association of Internal Medicine 2021
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7969064/
https://ncbi.nlm.nih.gov/pubmed/32088937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2019.330
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak